系统性白醇对吸烟者的非手术性牙周治疗的影响:一个为期12个月的随机临床试验
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。系统性白醇 (RSV) 在接受全口超声波除菌 (FMUD) 的吸烟者中改善了牙周健康. 这种疗法减少了探测深度,临床附着损失和IL-6等炎症标志物.
科学领域
- 牙周病学
- 药理学
- 免疫学
背景情况
- 吸烟是牙周炎的重要危险因素,影响治疗结果.
- 在临床前和临床研究中,复星 (RSV) 在减缓牙周炎进展方面表现有前途.
- 在接受牙周治疗的吸烟者中,没有先前的研究评估RSV的疗效.
研究的目的
- 评估系统性白醇 (RSV) 作为全口超声波除菌剂 (FMUD) 的辅助剂在患有牙周炎 (PSP) 的吸烟患者中的影响.
主要方法
- 三十八名患有牙周炎的吸烟患者被随机分为两个组:安慰剂 (n=19) 和RSV (每天500毫克,n=19).
- 这两组接受了FMUD,RSV组也接受了180天的每日白醇补充剂.
- 在治疗后12个月的不同时间点评估了临床,免疫炎症和微生物学结果.
主要成果
- 与安慰剂组相比,RSV组的探测深度 (PD),临床附着损失 (CAL) 和斑块质量增加 (PMG) 显著降低.
- 在3个月和6个月后,RSV的使用导致了Aggregatibacter actinomycetemcomitans (Aa) 的水平降低.
- 在RSV组中,免疫炎症标志物在3个月后降低IL- 1β,在3个月和12个月后降低IL- 6.
结论
- 综合使用RSV和FMUD,可显著改善患有牙周炎的吸烟患者的临床结果.
- 在牙周深处,RSV有效调节关键的炎症标志物 (IL-1β和IL-6).
- 这项研究强调了RSV作为治疗牙周炎的辅助疗法的潜力.
相关概念视频
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...